Programming Human Cells with Genetic Circuits: From Voigt’s Design Automation to Next-Generation Therapeutic Logic

Programming human cells with DNA is no longer the kind of wild, sci-fi thought experiment you’d scribble on a napkin after watching Gattaca—it’s happening, right now, in labs around the world. What once lived only as “proof-of-concept” is marching steadily toward clinical reality. At the heart of this shift is a deceptively simple idea: if we can write code for computers, why not write code for cells?

This is where Christopher Voigt’s work shines. His team built Cello, a kind of compiler for biology that turns high-level logic, (“if this, then that”)into actual DNA instructions. It’s like handing bacteria or human cells a circuit diagram and saying: Build this, then run it. And amazingly, they do.

But the story doesn’t end with Cello. In the past few years, new tools have exploded onto the scene:

This is the history of humanity learning to program life itself. Not in the metaphorical sense of “influencing nature,” but literally: writing code in DNA so that cells follow instructions like tiny biological computers. Over the last decade, researchers have assembled a toolkit of genetic switches, dials, and circuits that let us move from tinkering to actually designing. Four inventions stand out, each with its own story:

1.  CRISPRi and CRISPRa - the dimmer switches of genes.CRISPR started as a bacterial defense mechanism, and it gave us the genome editor that reshaped biology. But editing DNA isn’t always the goal, sometimes you just want to tune a gene rather than rewrite it. That’s where CRISPRi (interference) and CRISPRa (activation) come in. They take a disabled Cas9 enzyme, guide it to a target gene, and either block transcription like putting a finger on a record, or recruit activators to boost expression like turning up the volume. Instead of an on/off switch, these tools act more like dimmers, precisely adjusting gene activity to the level we need.

2.  RNA-level devices is the quick-response messengers.DNA changes are powerful, but they’re slow. By the time a genetic instruction is read, transcribed, and translated into protein, precious minutes or even hours may pass. RNA devices short-circuit that delay. They sense signals directly in the RNA transcripts, flipping genes on or off almost instantly. Think of them like text messages in a world of postal mail: fast, transient, and capable of carrying nuanced information. This speed makes RNA devices perfect for circuits where timing matters, like detecting a fleeting infection signal or shutting down a dangerous pathway before damage spreads.

3.  Translational modulators - the sound engineers of protein production.Even once RNA is made, there’s another crucial layer: translation into proteins. Translational modulators are molecular “mixing boards” that fine-tune this step. They can increase efficiency to flood the cell with a protein, or dampen it to avoid toxicity. Like a sound engineer balancing treble and bass at a concert, translational modulators make sure the cell produces the right protein at the right intensity—no screeching feedback, no missing notes. This level of control is vital when programming cells for therapeutic purposes, where too much or too little protein can mean the difference between cure and harm.

4.  Synthetic receptors like synNotch are the secret agents of cellular decision-making.Perhaps the most cinematic invention in this history is the synNotch receptor. Borrowing from natural signaling pathways, synNotch receptors sit on the cell surface like sentinels, waiting for an external cue. When the right antigen appears, they literally cut themselves in half, freeing a piece that travels into the nucleus to activate a chosen gene program. Scientists can wire them to act like secret agents: only when both of two enemy signals appear does the cell strike. In T-cell therapies, this is a lifesaver—engineered immune cells can be taught to ignore healthy tissue and unleash their attack only when they’re sure they’ve found a tumor. It’s logic-gated warfare, embedded in living cells.

Together, these breakthroughs are teaching us how to give cells not just instructions, but judgment, how to make them sense, decide, and act with precision.

Of course, no revolution is without its messy middle. Circuits misbehave when dropped into different cellular environments, DNA delivery is still clunky, and biology resists our tidy, engineering-style abstractions. Yet that’s also the thrill: biology doesn’t just follow rules, it writes them. And the next chapter is about learning to write alongside it.

If we can solve issues of context, safety, and standardization, the dream is breathtaking: closed-loop therapies that adjust themselves inside the body, living medicines compiled directly from code, and a future where “programming life” isn’t metaphor but standard clinical practice.

Cells as programmable substrates

Cello is built on a radical shift in perspective: cells are not just biological entities, they are programmable substrates. Genetic circuits—carefully engineered arrangements of promoters, operators, transcription factors, RNAs, and receptors—become the instructions. They take environmental inputs, like a chemical signal, and translate them into outputs: secretion of a therapeutic protein, halting of cell growth, or activation of an immune response.

What makes this powerful is not just the circuits themselves, but the infrastructure around them. Cello provides libraries of parts, formal design rules, and automated pipelines that map abstract logic onto DNA. It does for synthetic biology what CAD software did for electronics: turning messy, manual design into something structured, reproducible, and scalable.

The brilliance of Cello lies in its promise: abstract ideas, once trapped in the imagination of biologists, can now be compiled into real genetic code. Circuits that used to take months of trial and error can be designed in days, then built and tested like any other engineered system. This is not metaphor—it’s the literal transformation of biology into an information science.

RNA-level circuits: speed, orthogonality, and dynamic control

One of the most astonishing things about life is that it doesn’t just operate at the level of DNA. DNA is the long-term archive, the library of recipes. But the day-to-day business of being alive runs on RNA—the temporary notes, the sticky notes on the fridge of the cell. And so, if DNA circuits are like carefully drawn blueprints, RNA-level circuits are the quick sketches that let you move fast and change things on the fly.

The magic here is speed. RNA devices work in real time, responding almost immediately to changes in the cell. They don’t wait for DNA to be rewritten or re-read; they act on the transcripts already in play. And because they can be designed to operate orthogonally—that is, independently of the cell’s native transcription machinery—they expand what’s possible without stepping on the cell’s own toes.

Between 2023 and 2025, we’ve seen some miraculous advances. One is CARTRIDGE, a platform that repurposes Cas proteins—not as genome editors, but as translational modulators. Imagine being able to flip protein production ON or OFF with the clean precision of a light switch, but inside a living human cell. That’s CARTRIDGE.

Then there are de novo RNA switches that let us control RNA interference (RNAi) with exquisite precision. These switches mean you can knock down a specific gene only when and where you want—spatially in one tissue, temporally at one moment. It’s like having a scalpel made of logic instead of steel.

And finally, RNA-IN/RNA-OUT architectures, which sound like science fiction but are very real. These systems allow cells to sense arbitrary RNA molecules and then activate specific genetic responses. In plain terms: any RNA can become an input, and the cell can be programmed to reply in a predictable, engineered way.

Taken together, these tools feel infinite in their implications. They expand the palette of circuit design beyond the slow, sometimes clunky world of DNA promoters and transcription factors. Now, synthetic biologists can compose circuits that are faster, more flexible, and beautifully dynamic—using the same molecules that carry life’s most fleeting, yet essential, messages

Therapeutic applications: from cancer to diagnostics to manufacturing

Cancer is a puzzle not because it’s one disease, but because it’s many at once. A single tumor can be a chaotic city of different cell types, each one flying its own molecular flag, each one rewriting the rules as it grows. To make things worse, tumors don’t just sit there; they actively shape their neighborhoods with suppressive signals, tricking immune cells into standing down. And yet, here we are, programming T cells with circuits that can see through the chaos. These cells don’t respond to just one signal, but two or three in combination, like detectives checking multiple alibis before making an arrest. It’s no longer if X, then attack—it’s if X and Y, but not Z, then strike. For the first time, we are giving immune cells the logic to navigate the bewildering complexity of the tumor microenvironment. This is not just an incremental upgrade; it’s the difference between blunt force and surgical precision.

And while that’s happening inside patients, another revolution is unfolding in how we even make these therapies. Biomanufacturing has always been the hidden, fragile bottleneck of medicine—cells drifting off course, factories producing more chaos than product. But circuits are changing that. By embedding logic into production cells, we can stabilize their identities, balance their growth with their productivity, and standardize processes that once felt more like artisanal brewing than industrial science. Companies like Asimov are building the infrastructure of this new era: CAD for biology, part libraries for cells, automated pipelines for testing. It is the dream of programmable biomanufacturing becoming real—an orchestra of living factories that play in tune because we finally gave them sheet music.

And perhaps most astonishing of all: we are teaching cells to write history. With CRISPR-based recorders, every fleeting signal—a burst of inflammation, a developmental fork in the road, a viral invasion—can be etched into DNA like ink on a page. Cells become their own historians, carrying within them a record of where they’ve been and what they’ve endured. Imagine diagnosing a disease not by catching it in the act, but by reading the autobiography it left behind in your cells. Imagine reconstructing the hidden timeline of development, tracing the exact moment when health began to unravel. This is more than diagnostics; it’s memory itself, programmed into biology.

Compiling Life: Challenges

Every revolution comes with its own set of problems, and programming life is no exception. Circuits, for all their elegance on paper, behave differently once they collide with the messy reality of cells. This is what scientists call context dependence and burden: the way a genetic part that looks reliable in one location of the genome suddenly falters in another, or the way chromatin and cell type can muffle or amplify its effects. Cells aren’t blank slates; they’re crowded ecosystems. The fix? Borrowing tricks from control theory—feed-forward loops, insulation strategies, careful model calibration—to keep circuits stable in the chaos. It’s engineering, but with a constant reminder that biology has a mind of its own.

Then comes the question of delivery and integration. Designing a brilliant genetic program is useless if you can’t get it into the right cells safely. Viruses like AAV and lentivirus have carried much of the load, but they’re imperfect—limited cargo, insertional risks, immune reactions. Non-viral vectors are improving, targeted genomic “docking sites” are being explored, and new editors are stretching the limits of precision. Still, the bottleneck remains: how do we install software into the living without crashing the system?

And of course, there is the ever-present specter of specificity and safety. A receptor that mistakes healthy tissue for a tumor, a guide RNA that silences the wrong gene, a circuit that leaks activity when it’s supposed to be off—these are not minor bugs, they are catastrophic failures. To prevent them, scientists are layering logic: requiring multiple inputs before action, building orthogonal RNA controllers, even installing kill-switches that can wipe out engineered cells if they go rogue. It is equal parts programming and building fire escapes.

The last challenge is one that sounds mundane but may prove most profound: verification and standards. As circuits grow in complexity, ad-hoc testing won’t cut it. We need formal verification—proof that what you wrote in the specification is what ended up in the DNA. We need unit tests, curated libraries, standardized data formats. This is where Cello’s automation pipeline was a preview of the future: biology written, compiled, tested, and debugged like code. Without standards, there is no scaling.

And yet, even with these obstacles, the outlook feels astonishing. Voigt’s radical idea—that you could take a high-level specification and compile it into DNA—is no longer confined to bacteria. It is unfolding in human cells, where synNotch receptors deliver logic at the membrane, RNA devices deliver speed inside the cytoplasm, and CRISPR regulators tune transcription with breathtaking precision. The field is converging toward circuits that are composable, multi-layered, and executed in primary human cells.

The next breakthroughs are already visible: universal libraries of mammalian parts trained by machine learning; fully integrated design-build-test-learn platforms powered by single-cell multi-omics; regulatory frameworks that treat programmable behavior not as a risk but as a controllable, testable property of medicines.

We are entering a world where therapies can be written like code and compiled into living medicines. Not metaphor, but practice. The century when biology stopped being only descriptive and became programmable. And once you see that, it is hard to imagine a more exhilarating or more consequential discovery.